Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
April 23, 2016
Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist
Tom Macleod, Rosella Doble, Dennis McGonagle, et al.
RMD Open
|
May 25, 2024
Pronounced benefits of JAK inhibition with baricitinib in COVID-19 pneumonia in obese but not lean subjects
Paula David, Or Hen, Niv Ben-Shabbat, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 19, 2024
Epidermal proteomics demonstrates Elafin as a psoriasis-specific biomarker and highlights increased anti-inflammatory activity around psoriatic plaques
Anna Berekmeri, Tom Macleod, Isabel Hyde, et al.
RMD Open
|
December 19, 2023
Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis
Nathan J Dean, Ian J Clifton, Rashad Salman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2017
Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ
Joseph S Ainscough, Tom Macleod, Dennis McGonagle, et al.
Frontiers in Immunology
|
March 15, 2018
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
Charlie Bridgewood, Gareth W Fearnley, Anna Berekmeri, et al.
The Journal of Investigative Dermatology
|
April 8, 2022
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases
Charlie Bridgewood, Miriam Wittmann, Tom Macleod, et al.
Frontiers in Immunology
|
December 1, 2025
Human spinal enthesis comparative biology of IL-17F and IL-17A reveals greater T-cell IL-17F induction and IL-23 regulation
Nicole McDermott, Ala Altaie, Tom Macleod, et al.
Journal of Autoimmunity
|
June 17, 2026
Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition
Antonio Tonutti, Vlad Voiculescu, Francesca Trunfio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 22, 2025
Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic Role
Kerem Abacar, Gabriele De Marco, Jake Weddell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
April 23, 2016
Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist
Tom Macleod, Rosella Doble, Dennis McGonagle, et al.
RMD Open
|
May 25, 2024
Pronounced benefits of JAK inhibition with baricitinib in COVID-19 pneumonia in obese but not lean subjects
Paula David, Or Hen, Niv Ben-Shabbat, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 19, 2024
Epidermal proteomics demonstrates Elafin as a psoriasis-specific biomarker and highlights increased anti-inflammatory activity around psoriatic plaques
Anna Berekmeri, Tom Macleod, Isabel Hyde, et al.
RMD Open
|
December 19, 2023
Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis
Nathan J Dean, Ian J Clifton, Rashad Salman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2017
Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ
Joseph S Ainscough, Tom Macleod, Dennis McGonagle, et al.
Frontiers in Immunology
|
March 15, 2018
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
Charlie Bridgewood, Gareth W Fearnley, Anna Berekmeri, et al.
The Journal of Investigative Dermatology
|
April 8, 2022
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases
Charlie Bridgewood, Miriam Wittmann, Tom Macleod, et al.
Frontiers in Immunology
|
December 1, 2025
Human spinal enthesis comparative biology of IL-17F and IL-17A reveals greater T-cell IL-17F induction and IL-23 regulation
Nicole McDermott, Ala Altaie, Tom Macleod, et al.
Journal of Autoimmunity
|
June 17, 2026
Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition
Antonio Tonutti, Vlad Voiculescu, Francesca Trunfio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 22, 2025
Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic Role
Kerem Abacar, Gabriele De Marco, Jake Weddell, et al.
Page
of 3